AVOL:SIXAvolta AG Analysis
Data as of 2026-03-11 - not real-time
CHF 47.52
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Avolta’s share price sits just below its 20‑day and 50‑day moving averages, while the 200‑day average remains supportive, indicating a short‑term pull‑back within a longer‑term uptrend. The MACD has turned bearish and the RSI hovers around the mid‑40s, suggesting limited upside momentum, yet volume is on the rise and the 30‑day volatility is markedly high, reflecting a nervous market that is currently in an "Extreme Greed" sentiment environment.
Fundamentally, the company delivers solid gross margins above 60% but struggles with thin operating and net margins, a modest revenue growth rate, and an alarming debt‑to‑equity profile that dwarfs its cash reserves. The dividend yield of just over 2% is backed by a payout ratio exceeding earnings, raising concerns about sustainability, while the forward P/E around 12 contrasts sharply with a trailing P/E near 60, and a DCF‑derived fair value points to potential upside despite the current price level.
Fundamentally, the company delivers solid gross margins above 60% but struggles with thin operating and net margins, a modest revenue growth rate, and an alarming debt‑to‑equity profile that dwarfs its cash reserves. The dividend yield of just over 2% is backed by a payout ratio exceeding earnings, raising concerns about sustainability, while the forward P/E around 12 contrasts sharply with a trailing P/E near 60, and a DCF‑derived fair value points to potential upside despite the current price level.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price hovering near recent support
- bearish MACD divergence
- high leverage raising balance‑sheet concerns
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- forward earnings expansion potential
- undervalued DCF estimate
- recovering travel retail demand
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- strong gross margins and diversified global footprint
- opportunity to deleverage over time
- sustained dividend yield if earnings improve
Key Metrics & Analysis
Financial Health
Revenue Growth4.20%
Profit Margin0.84%
P/E Ratio59.4
ROE12.14%
ROA3.90%
Debt/Equity599.85
P/B Ratio3.7
Op. Cash FlowCHF2.8B
Free Cash FlowCHF1.6B
Technical Analysis
TrendBullish
RSI47.2
SupportCHF 43.88
ResistanceCHF 52.90
MA 20CHF 49.14
MA 50CHF 48.31
MA 200CHF 45.13
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair ValueCHF 109.46
Target PriceCHF 51.86
Upside/Downside9.14%
GradeFair
TypeBlend
Dividend Yield2.18%
Risk Assessment
Beta0.43
Volatility39.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.